数位疗法市场规模、份额和成长分析（按交付类型、应用、收入模式、销售管道和地区划分）—2026-2033年行业预测

全球数位疗法市场规模预计在 2024 年达到 40.1 亿美元，从 2025 年的 46.8 亿美元成长到 2033 年的 159.9 亿美元，在预测期（2026-2033 年）内复合年增长率为 16.61%。

全球数位疗法市场正迅速发展，整合先进技术、服务和产品，以提升医疗保健和健康促进水平。这些解决方案利用行动应用、机器学习、巨量资料和人工智慧，为心血管疾病、癌症和糖尿病等慢性病提供个人化治疗方案。智慧型手机在全球的普及，尤其是在开发中国家，正在推动对数位健康解决方案的需求，并带来巨大的成长机会。远端医疗现代医疗保健策略的关键组成部分，强调医疗服务的安全性、品质和以患者为中心的理念。

全球数位疗法市场按交付方式、应用领域、收入模式、销售管道和地区进行细分。依交付方式划分，可分为软体/平台、程式和虚拟实境/游戏。依应用领域划分，可分为治疗/护理相关应用与预防应用。依收入模式划分，可分为订阅模式、一次性购买/年度授权模式和基于结果/价值的模式。依销售管道，可分为B2B销售管道及B2C销售管道。按地区划分，可分为北美、欧洲、亚太、中东和非洲以及拉丁美洲。

全球数位疗法市场驱动因素

全球数位疗法市场正经历显着成长，这主要得益于对用于管理和治疗慢性疾病的治疗软体和设备的需求不断增长。包括糖尿病、多种癌症、阿兹海默症、肥胖症和胃肠道疾病在内的各种慢性疾病的盛行率正在上升。这一趋势在新兴经济体尤为明显，从而推动了对创新数位解决方案的需求。随着医疗服务提供者和患者寻求有效的管理工具，数位疗法的应用日益普及，这反映出人们越来越认识到数位疗法在改善不同患者群体健康方面的潜力。

全球数位疗法市场面临的限制因素

全球数位疗法市场以创新软体和设备驱动的解决方案为特征，旨在预防、管理和治疗各种疾病。然而，诸多限制阻碍了其发展。其中一个关键因素是日益严重的网路安全问题，这引发了人们对患者资料安全的严重担忧，并阻碍了数位疗法的广泛应用。此外，监管政策不明朗、报销难题以及技术取得方面的差异也进一步阻碍了市场扩张。随着患者对自身医疗资讯潜在风险的认识不断提高，这些因素也使得数位疗法解决方案在医疗机构中的应用变得更加复杂。

全球数位疗法市场趋势

全球数位疗法市场的一个显着趋势是人工智慧 (AI) 和机器学习技术的日益融合，以实现个人化治疗并提升病人参与。这些先进技术能够开发出更有效、更具适应性的治疗方法，以满足个别患者的需求并利用即时健康数据。此外，随着人们对心理健康和慢性病管理的认识不断提高，医疗服务提供者和患者的接受度也日益增强，这进一步推动了市场成长。这一趋势凸显了远距远端医疗。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 专利分析
• 技术分析
• 案例研究

全球数位疗法市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 软体/平台
• 程式
• 虚拟实境/游戏

全球数位疗法市场规模（按应用领域及复合年增长率划分）（2026-2033 年）

• 治疗和护理应用
  • 糖尿病
  • 中枢神经系统（CNS）疾病
  • 精神疾病
  • 其他中枢神经系统疾病
  • 禁止抽烟
  • 慢性呼吸系统疾病
  • 肌肉骨骼疾病
  • 心血管疾病
  • 用药依从性
  • 消化系统疾病
  • 復健和患者照护
  • 物质使用疾患与成瘾管理
  • 其他治疗和护理应用
• 预防性应用
  • 糖尿病前期
  • 肥胖
  • 营养
  • 生活方式管理
  • 其他预防性应用

全球数位疗法市场规模（按收入模式和复合年增长率划分）（2026-2033 年）

• 订阅模式
• 一次性购买/年度授权模式
• 结果/价值导向模型

全球数位疗法市场规模（按销售管道和复合年增长率划分）（2026-2033 年）

• B2B销售管道
  • 付款人
  • 雇主
  • 製药公司
  • 医疗保健提供者
  • 其他买家
• B2C销售管道
  • 看护者
  • 病人

全球数位疗法市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Noom, Inc
• Teladoc Health, Inc.
• Omada Health, Inc.
• WellDoc, Inc
• Biofourmis
• Better Therapeutics, Inc
• Amalgm Rx
• CogniFit Inc
• Headspace Health
• Propeller Health
• Virta Health Corp
• 2Morrow, Inc.
• Realizedcare（via XRHealth）
• Canary Health
• Twill Inc.
• Click Therapeutics, Inc.
• Akili, Inc.
• Cognoa, Inc
• Wellthy Therapeutics Pvt. Ltd.
• Kaia Health

结论与建议

Global Digital Therapeutics Market size was valued at USD 4.01 Billion in 2024 and is poised to grow from USD 4.68 Billion in 2025 to USD 15.99 Billion by 2033, growing at a CAGR of 16.61% during the forecast period (2026-2033).

The global digital therapeutics market is rapidly evolving, integrating advanced technologies, services, and products to enhance healthcare and wellness. Leveraging mobile apps, machine learning, big data, and artificial intelligence, these solutions provide personalized treatment regimens, targeting chronic diseases such as cardiovascular conditions, cancer, and diabetes. As smartphone adoption rises globally, particularly in developing nations, the demand for digital health solutions is increasing, presenting significant growth opportunities. Notably, telemedicine is gaining traction in low-income areas, connecting patients to necessary healthcare resources while reducing infrastructure costs. With a growing elderly population and a rising burden of chronic diseases, digital therapeutics is positioned as a crucial element in contemporary healthcare strategies, emphasizing safety, quality, and patient-centered principles in treatment delivery.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Therapeutics Market Segments Analysis

Global digital therapeutics market is segmented on the basis of Offering, Application, Revenue Model, Sales Channel, and region. By Offering, the market is segmented into Software/Platforms, Programs, and Virtual Reality/Games. By Application, the market is segmented into Treatment/Care-Related Applications. Preventive Applications. By Revenue Model, the market is segmented into Subscription-Based Model, One-Time Purchase/Annual Licensing Model, Outcome /Value-Based Model. By Sales Channel, the market is segmented into B2B Sales Channel and B2C Sales Channels. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Global Digital Therapeutics Market

The Global Digital Therapeutics market is experiencing significant growth driven by the rising demand for therapeutic software and devices aimed at managing and treating chronic diseases worldwide. The prevalence of chronic conditions, including various forms of diabetes, cancers, Alzheimer's disease, obesity, and gastrointestinal disorders, is on the rise. This trend is particularly pronounced in emerging economies, where there is heightened demand for innovative digital solutions. As healthcare providers and patients increasingly seek effective management tools, the adoption of digital therapeutics is expanding, reflecting a growing recognition of their potential to enhance health outcomes in diverse patient populations.

Restraints in the Global Digital Therapeutics Market

The Global Digital Therapeutics market is characterized by innovative software and device-driven solutions designed to prevent, manage, or treat various medical conditions. However, several constraints are hindering its growth. Chief among these are escalating cybersecurity issues, which raise significant concerns regarding the safety of patient data and limit the widespread acceptance of digital therapeutics. Additionally, a lack of regulatory clarity coupled with challenges related to reimbursement and unequal access to technology further obstructs market expansion. As patients become increasingly aware of potential risks associated with their medical information, these factors complicate the adoption of digital therapeutic solutions in healthcare settings.

Market Trends of the Global Digital Therapeutics Market

A significant trend in the global digital therapeutics market is the increasing integration of artificial intelligence and machine learning technologies to enhance treatment personalization and patient engagement. These advanced capabilities allow for the development of more effective, adaptive therapies that cater to individual patient needs and real-time health data. Additionally, growing acceptance among healthcare providers and patients, driven by rising awareness of mental health and chronic disease management, further fuels market expansion. This trend underscores the ongoing shift toward remote care solutions, improving accessibility, and bridging the gap between traditional healthcare delivery and innovative digital health interventions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Digital Therapeutics Market Size by Offering & CAGR (2026-2033)

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Global Digital Therapeutics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental health disorders
  • Other CNS disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Global Digital Therapeutics Market Size by Revenue Model & CAGR (2026-2033)

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Global Digital Therapeutics Market Size by Sales Channel & CAGR (2026-2033)

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Global Digital Therapeutics Market Size & CAGR (2026-2033)

• North America (Offering, Application, Revenue Model, Sales Channel)
  • US
  • Canada
• Europe (Offering, Application, Revenue Model, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Application, Revenue Model, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Application, Revenue Model, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Application, Revenue Model, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Noom, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omada Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellDoc, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biofourmis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Better Therapeutics, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amalgm Rx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CogniFit Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Headspace Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Propeller Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virta Health Corp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 2Morrow, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Realizedcare (via XRHealth)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canary Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Twill Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Click Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akili, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognoa, Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wellthy Therapeutics Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaia Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations